# US 2008/0188553 A1 · Novel ascorbic acid compounds, methods of synthesis and application use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188553 A1
- Document ID: US20080188553A1
- Status: Published application
- Kind: A1
- Application number: 11/671,920
- Filed: 2007-02-06
- Published: 2008-08-07
- Earliest claimed: 2007-02-06
- Inventors: WAHEED M ROOMI
- Web page: https://patentgrep.com/patent/US20080188553A1

## CPC

- A61K 31/34: having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A composition of L-ascorbic acid derivatives is described comprising L-ascorbic acid and lysine or lysine moieties, wherein L-ascorbic acid is covalently bound to the lysine or lysine moieties. The composition so described is used to prevent the degradation of extracellular matrix, stabilize connective tissue, is used to as an antioxidant, and is used for treating damage to skin comprising applying the topical composition to the skin.

## Claims

### Claim 1

A composition of L-ascorbic acid derivatives, comprising: a. L-ascorbic acid and b. lysine or lysine moieties, wherein L-ascorbic acid is covalently bound to the lysine or lysine moieties.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the L-ascorbic acid is covalently bound to the lysine or lysine moieties in the C-6 position of the L-ascorbic acid.

### Claim 3 (depends on 1)

The composition of claim 1 wherein the L-ascorbic acid is covalently bound to the lysine or lysine moieties in the C-2 position of the L-ascorbic acid.

### Claim 4 (depends on 1)

The composition of claim 1 wherein the 1-ascorbic acid is covalently bound to one or more lysine in C-6 position of the L-ascorbic acid.

### Claim 5 (depends on 1)

The composition of claim 1 wherein the L-ascorbic acid is covalently bound to one or more lysine in C-2 position of the L-ascorbic acid.

### Claim 6 (depends on 1)

The composition of claim 1 wherein L-ascorbic acid is covalently bound to a first lysine in C-6 position and a second lysine in C-2 position of the L-ascorbic acid.

### Claim 7 (depends on 1)

The composition of claim 1 wherein the L-ascorbic acid is covalently bound to two or more lysine in C-6 position and one lysine in C-2 position of the L-ascorbic acid.

### Claim 8 (depends on 1)

The composition of claim 1 wherein the L-ascorbic acid is covalently bound to one lysine in C-6 position and two or more lysine in C-2 position L-ascorbic acid.

### Claim 9 (depends on 1)

The composition of claim 1 wherein L-ascorbic, acid is covalently bound to two or more lysine in C-6 position and two or more lysine in C-2 position of the L-ascorbic acid.

### Claim 10

A composition of L-ascorbic acid derivatives, comprising: a. L-ascorbic acid and b. proline or proline moieties wherein the proline or proline moieties are covalently bound to L-ascorbic acid.

### Claim 11 (depends on 10)

The composition of claim 10 wherein the L-ascorbic acid is covalently bound to proline in C-6 position of the L-ascorbic acid.

### Claim 12 (depends on 10)

The composition of claim 10 wherein the L-ascorbic acid is covalently bound to proline in C-2 position of the L-ascorbic acid.

### Claim 13 (depends on 10)

The composition of claim 10 wherein the L-ascorbic-acid is covalently bound to two or more proline in C-6 position of the L-ascorbic acid.

### Claim 14 (depends on 10)

The composition of claim 10 wherein the L-ascorbic acid is covalently bound to two or more proline in C-2 position of the L-ascorbic acid.

### Claim 15 (depends on 10)

The composition of claim 10 wherein the L-ascorbic acid is covalently bound to a first proline in C-6 position of the L-ascorbic acid and a second proline in C-2 position of the L-ascorbic acid.

### Claim 16 (depends on 10)

The composition of claim 10 wherein L-ascorbic acid is covalently bound to a proline in C-2 position of the L-ascorbic acid and a polyproline in C-6 position of the L-ascorbic acid.

### Claim 17 (depends on 10)

The composition of claim 10 wherein the L-ascorbic acid is covalently bound to a polyproline in C-2 position of the L-ascorbic acid and a proline molecule in C-6 position of the L-ascorbic acid.

### Claim 18 (depends on 10)

The composition of claim 10 wherein the L-ascorbic acid is covalently bound to a first polyproline at C-2 position of the L-ascorbic acid and a second polyproline at C-6 position of the L-ascorbic acid.

### Claim 19

A pharmaceutical composition comprising an L-ascorbic acid derivative as an effective ingredient, together with a pharmaceutical acceptable carrier, wherein the L-ascorbic acid derivative is selected from the group consisting of ascorbyl-6-lysine, ascorbyl-2-lysine, ascorbyl-6-polylysine, ascorbyl-2,6-dilysine, ascorbyl-6-polylysine-2-lysine, ascorbyl-6-lysine-2-polylysine, ascorbyl-2,6-polylysine, ascorbyl-6-proline, ascorbyl-2-proline, ascorbyl-6-polyproline, ascorbyl-2-polyproline, ascorbyl-2,6-diproline, ascorbyl-2-proline-6-polyproline, ascorbyl-2-polyproline-6-proline, ascorbyl-2,6-diproline, 6deoxyascrobyllysine. 6-deoxyascorbylproline, 6-deoxyascorbylpolylysine, 6deoxyascorbylpolyproline, 6-deoxyascorbyllysine-2-proline, 6-deoxyascorbylproline-2-lysine, 6-deoxyascorbylpolylysine-2-proline 6-deoxyascorbylpolyproline-2-lysine, 6-deoxyascorbyllysine-1-polyproline. 6-deoxyascorbylproline-2-polylysine, 6-deoxyascorbate proline-2-lysine-proline 6-deoxyascorbate-2-proline-lysine, 6-deoxyascorbyllysine, 6-deoxyascorbate-lysine-proline, 6-deoxyascorbyl-lysine-2-proline, 6-deoxyascorbyl-polylysine-2-proline, 6-deoxyascorbyl-lysine-2-polyproline, 6-deoxyascorbyl-lysine-2lysine-proline, 6-deoxyamino ascorbyl-polylysine, 6-deoxyamino ascorbyl-lysine-proline, 6-deoxyamino ascorbylproline, 6-deoxyamino ascorblylpolyproline.

### Claim 20 (depends on 19)

The composition of claim 19 wherein the composition is used to prevent the degradation of extracellular matrix.

### Claim 21 (depends on 19)

The composition of claim 19 wherein the composition is used to stabilize connective tissues.

### Claim 22 (depends on 19)

The composition of claim 19 wherein the composition is used to as an antioxidant.

### Claim 23 (depends on 19)

The composition of claim 19, wherein the composition is used for treating damage to skin comprising applying the topical composition to the skin.
